HD-OPM Archive
Topics › Statins

Review: statins may benefit chronic liver disease and cirrhosis

Louis Nervegna · May 19, 2025 · ♥ 1 reactions · 0 comments · original Facebook post
StatinsWeight, visceral & liver fat
↻ This is a repost. The main version (highest ranked) is Statins may benefit chronic liver disease rather than harm it, per a review · Jul 16, 2024.
AI summary & key facts

Louis quotes a review that statins, once feared harmful to the liver, may benefit chronic liver disease and cirrhosis, though trials are needed.

(no text — see the shared post below)

Research cited

Are statins harmful to the liver in the long term?

Newer evidence suggests the opposite.

Quoted:

“Statins were initially considered harmful agents for the liver, but current evidence now suggests that this drug class may have beneficial effects in some CLD [Chronic Liver Diseases] as well as a potentially positive impact on the natural history and complications of cirrhosis. However, prospective interventional studies and randomized trial need to be carried out to confirm these observations. If the benefits of statins in CLD are confirmed, hepatologists will achieve better outcomes in their patients without significant additional costs.”

“Chronic liver disease (CLD), cirrhosis, and its complications, including hepatocellular carcinoma (HCC), are significant public health problems. The use of statins in patients with CLD has been a matter of concern, and physicians are often reluctant to its prescription in these patients. This mainly relates to the potential occurrence of drug-induced liver injury. However, newer evidence from pre-clinical and clinical research has shown that statins are drugs with a potentially beneficial impact on the natural history of cirrhosis, on portal hypertension, and in HCC prevention.”

#statinsliverHD #liverHD #statinsHD

← newer: Statin use linked to lower liver cancer and decompensation iolder: About 1 in 1,000 statin users has a statin-related liver tes →